These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 15581048)
1. Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress. Hwang SS; Scott CB; Chang VT; Cogswell J; Srinivas S; Kasimis B Cancer Invest; 2004; 22(5):678-87. PubMed ID: 15581048 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal quality of life in advanced cancer patients: pilot study results from a VA medical cancer center. Hwang SS; Chang VT; Fairclough DL; Cogswell J; Kasimis B J Pain Symptom Manage; 2003 Mar; 25(3):225-35. PubMed ID: 12614957 [TBL] [Abstract][Full Text] [Related]
3. The memorial symptom assessment scale short form (MSAS-SF). Chang VT; Hwang SS; Feuerman M; Kasimis BS; Thaler HT Cancer; 2000 Sep; 89(5):1162-71. PubMed ID: 10964347 [TBL] [Abstract][Full Text] [Related]
4. Reliability and Validity of the Korean Memorial Symptom Assessment Scale-Short Form in Gynecological Cancer Patients. Nho JH; Kim SR; Chang VT; Nam JH J Pain Symptom Manage; 2018 Jan; 55(1):101-107. PubMed ID: 28865872 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Nieder C; Nestle U; Motaref B; Walter K; Niewald M; Schnabel K Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):297-302. PubMed ID: 10661335 [TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article. Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745 [TBL] [Abstract][Full Text] [Related]
7. Quality of life and survival: the role of multidimensional symptom assessment. Chang VT; Thaler HT; Polyak TA; Kornblith AB; Lepore JM; Portenoy RK Cancer; 1998 Jul; 83(1):173-9. PubMed ID: 9655308 [TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center. Hwang SS; Chang VT; Cogswell J; Kasimis BS Cancer; 2002 May; 94(9):2481-9. PubMed ID: 12015774 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of survival in patients with advanced cancer admitted to home care. Mercadante S; Valle A; Porzio G; Aielli F; Adile C; Casuccio A; J Pain Symptom Manage; 2013 Jan; 45(1):56-62. PubMed ID: 23017625 [TBL] [Abstract][Full Text] [Related]
10. Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients. Webber K; Davies AN J Pain Symptom Manage; 2011 Nov; 42(5):761-7. PubMed ID: 21530154 [TBL] [Abstract][Full Text] [Related]
11. A comparison of three fatigue measures in veterans with cancer. Hwang SS; Chang VT; Kasimis BS Cancer Invest; 2003 Jun; 21(3):363-73. PubMed ID: 12901282 [TBL] [Abstract][Full Text] [Related]
12. Patient-Reported Outcomes for Determining Prognostic Groups in Veterans With Advanced Cancer. Chang VT; Scott CB; Gonzalez ML; Einhorn J; Yan H; Kasimis BS J Pain Symptom Manage; 2015 Sep; 50(3):313-20. PubMed ID: 25912275 [TBL] [Abstract][Full Text] [Related]
13. Validation of the Edmonton Symptom Assessment Scale. Chang VT; Hwang SS; Feuerman M Cancer; 2000 May; 88(9):2164-71. PubMed ID: 10813730 [TBL] [Abstract][Full Text] [Related]
14. Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer. Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1169-76. PubMed ID: 18938045 [TBL] [Abstract][Full Text] [Related]
15. The clinical utility of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in Turkish lung cancer patients. Yüceege M; Sanisoğlu B; Fırat H; Ersoy Y; Sevgi E; Kurt EB Clin Respir J; 2015 Apr; 9(2):221-7. PubMed ID: 25849299 [TBL] [Abstract][Full Text] [Related]
17. KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy. Partl R; Fastner G; Kaiser J; Kronhuber E; Cetin-Strohmer K; Steffal C; Böhmer-Breitfelder B; Mayer J; Avian A; Berghold A Support Care Cancer; 2016 Feb; 24(2):523-528. PubMed ID: 26105515 [TBL] [Abstract][Full Text] [Related]
18. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Brown DJ; McMillan DC; Milroy R Cancer; 2005 Jan; 103(2):377-82. PubMed ID: 15558809 [TBL] [Abstract][Full Text] [Related]
19. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy. Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661 [TBL] [Abstract][Full Text] [Related]
20. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Nieder C; Andratschke N; Grosu AL; Molls M Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]